Josiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee, & Jessica Weaver. (2024). Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJosiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee, and Jessica Weaver. Potential Serotype-specific Effectiveness Against IPD of Pneumococcal Conjugate Vaccines V114 and PCV20 in Children Given a 2+1 Dosing Regimen. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationJosiah Ryman, et al. Potential Serotype-specific Effectiveness Against IPD of Pneumococcal Conjugate Vaccines V114 and PCV20 in Children Given a 2+1 Dosing Regimen. Taylor & Francis Group, 2024.